Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saxagliptin and Sildenafil Interaction Study
NCT04170790Phase 1Unknown
- Sponsor
- Ain Shams University
- Start
- Dec 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of saxagliptin in type 2 diabetes mellitus (T2DM), sponsored by Ain Shams University. Primary endpoints: Maximum Plasma Concentration at Day 13, Area Under the Curve from time zero to infinity at Day 13 and 7 more. Status: unknown.
02
Drugs
saxagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04170790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04170790.